Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis.

Source:http://linkedlifedata.com/resource/pubmed/id/18056404

J. Immunol. 2007 Dec 15 179 12 8562-7

Download in:

View as

Triples

General Info

PMID
18056404